2026-06-29 — Argentina's Puna Bio raised $20.3M, led by Corteva Catalyst with the Gates Foundation participating, to expand its extremophile-derived…
Puna Bio, an Argentina-based biologicals company, has raised $20.3 million to expand internationally. Corteva Catalyst led the round, which also drew participation from the Gates Foundation.
Puna Bio develops biologicals derived from extremophile microorganisms, organisms adapted to harsh environments, aimed at supporting crops in climate-stressed farming conditions.
The investment signals continued confidence in input-science approaches that offer alternatives to synthetic chemistries, particularly where regulatory pressure on conventional inputs is rising.
Puna Bio raises $20.3M for extremophile-derived biologicals
Argentina's Puna Bio raised $20.3M, led by Corteva Catalyst with the Gates Foundation participating, to expand its extremophile-derived biologicals internationally.
Puna Bio, an Argentina-based biologicals company, has raised $20.3 million to expand internationally. Corteva Catalyst led the round, which also drew participation from the Gates Foundation.
Puna Bio develops biologicals derived from extremophile microorganisms, organisms adapted to harsh environments, aimed at supporting crops in climate-stressed farming conditions.
The investment signals continued confidence in input-science approaches that offer alternatives to synthetic chemistries, particularly where regulatory pressure on conventional inputs is rising.
